Navigation Links
AdvaMed Supports Comprehensive Tax Reform Repeal of the Medical Device Tax Important First Step
Date:7/9/2013

WASHINGTON, July 8, 2013 /PRNewswire-USNewswire/ -- Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), released the following statement in response to tax-writing committee Chairmen Camp and Baucus as they begin their nationwide listening tour in favor of a simpler, fairer U.S. tax code: 

"AdvaMed commends the efforts of Ways and Means Committee Chairman Dave Camp (R-MI) and Senate Finance Committee Chairman Max Baucus (D-MT) to advance comprehensive U.S. tax reform to improve America's competitiveness and rebuild our nation's economic future. We look forward to working with them as they develop their legislation.

"As they begin their Tax Reform Tour in the Minneapolis-St. Paul, Minnesota area, it is important to note the medical technology industry supports over 35,000 jobs in the state and more than two million jobs nationally. In the context of reforming the tax code to make U.S. business more competitive, repealing the medical device excise tax that went into effect in January is a critical first step to protecting these jobs and ensuring a level playing field for Minnesota and the rest of the U.S. in the global economy.

"America's current corporate tax structure is a key factor contributing to the decline of the competitiveness of the American medical technology industry. U.S. corporate tax rates are the highest in the world. The U.S. has failed to match competitor nations in positive tax incentives to attract knowledge-based, high-value manufacturing industries like medical technology. The U.S. tax code provides few incentives to invest in the pre-profit start-up companies that are the backbone of the innovation system.

"The device tax makes an already uncompetitive tax system for the medical technology industry far less competitive and threatens our industry's continued world leadership. It raises the total tax burden for our industry by a whopping 29% – resulting in fewer job opportunities, lower R&D investment to fuel tomorrow's treatments and cures, and/or higher health care costs.

"Legislative measures to repeal the device tax passed the House last summer and the Senate in March with overwhelming bipartisan majorities. Congress and the President must act now to finish the job and repeal it."

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.


'/>"/>
SOURCE AdvaMed
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AdvaMed & BioOhio Discuss MedTech Impact on Ohios Economy, Job Creation
2. AdvaMed Commends House Progress on Repealing Medical Device Tax
3. Countdown Begins For AdvaMed 2012: The Medtech Conference
4. AdvaMed Launches MVP Mentoring Portal for Veterans
5. AdvaMed Opposes Puerto Rico Medical Device Tax Increase
6. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
7. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
8. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
9. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
10. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
11. Ventana Supports World Patient Safety Day, July 25
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... 2016  ValGenesis, Inc., the market leader ... today announced that a prominent world provider ... chronic kidney failure has selected ValGenesis Validation ... validation process. The global medical device manufacturer ... manage their validation processes electronically. Upon completion ...
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... The number of chronically ... aging – meaning that there is an urgent need for highly skilled care managers ... solution, delivering a multi-pronged approach to train and retain care managers, and enhance their ...
(Date:4/28/2016)... ... ... offering a special deal on its webstore. , Buy 1 product and get ANYTHING (including ... with lesser value. In addition, a free bonus of 3 top serums in a ... many women (men, too) love our products and get good results. We want to introduce ...
(Date:4/28/2016)... Oaks, CA (PRWEB) , ... April 28, 2016 , ... ... is currently number one in Central America and is looking to grow their market ... marketing for such an exceptional brand as La Sirena Foods and indirectly ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... a new CDISC standard, Clinical Trial Registry (CTR) XML. Clinical trial registries ... will make it possible to build applications that generate submissions for multiple, ...
(Date:4/28/2016)... West Palm Beach, FL (PRWEB) , ... April 28, 2016 , ... ... time for the spring season. Smart pots are frequently used by professional organic farmers ... time for growers to order their supply of fabric pots. Our goal is to ...
Breaking Medicine News(10 mins):